OCX Logo

OncoCyte Corporation (OCX) 

NASDAQ
Market Cap
$33.17M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
42 of 945
Rank in Industry
33 of 538

Largest Insider Buys in Sector

OCX Insider Trading Activity

OCX Median Price and Trade Amounts History Chart

About OncoCyte Corporation

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.

Insider Activity of OncoCyte Corporation

Over the last 12 months, insiders at OncoCyte Corporation have bought $11.45M and sold $0 worth of OncoCyte Corporation stock.

On average, over the past 5 years, insiders at OncoCyte Corporation have bought $12.61M and sold $73,802 worth of stock each year.

Highest buying activity among insiders over the last 12 months: BROADWOOD PARTNERS, L.P. (10 percent owner) — $43.74M. SMITH PATRICK W (10 percent owner) — $473,117. Arno Andrew (director) — $252,698.

The last purchase of 25 shares for transaction amount of $51 was made by SMITH PATRICK W (10 percent owner) on 2025‑02‑04.

List of Insider Buy and Sell Transactions, OncoCyte Corporation

2025-02-04Purchase10 percent owner
25
0.0001%
$2.02$51-2.82%
2025-01-31Purchase10 percent owner
890
0.0053%
$2.01$1,789-4.61%
2025-01-30Purchase10 percent owner
318
0.0019%
$2.01$639+1.72%
2025-01-29Purchase10 percent owner
3,880
0.0228%
$2.01$7,799+2.26%
2025-01-14Purchase10 percent owner
10,386
0.0608%
$2.15$22,323-3.72%
2025-01-13Purchase10 percent owner
5,669
0.0337%
$2.08$11,792-0.48%
2024-12-26Purchase10 percent owner
90,219
0.5436%
$2.13$192,166-1.41%
2024-12-26Purchasedirector
12,500
0.0745%
$2.11$26,350-1.41%
2024-12-05PurchaseChief Financial Officer
20,000
0.1168%
$2.29$45,800-6.09%
2024-10-02Purchase10 percent owner
1.32M
9.7663%
$2.95$3.88M-20.00%
2024-10-02PurchaseChief Financial Officer
33,670
0.2519%
$2.97$100,000-20.00%
2024-04-11Purchase10 percent owner
2.42M
28.8149%
$2.92$7.06M-6.06%
2024-04-11Purchasedirector
33,898
0.4083%
$2.95$99,999-6.06%
2024-04-11PurchaseCEO and President
3,390
0.0408%
$2.95$10,001-6.06%
2023-06-14Purchasedirector
30,000
0.0246%
$0.21$6,447-30.23%
2023-04-05Purchase10 percent owner
663,000
0.6681%
$0.30$200,027-37.96%
2023-04-03Purchase10 percent owner
26.83M
23.0078%
$0.30$8.09M-47.13%
2022-12-23Purchasedirector
250,000
0.2087%
$0.35$87,875-43.42%
2022-12-23Purchasedirector
75,000
0.0587%
$0.33$24,728-43.42%
2022-12-22Purchasedirector
25,000
0.0218%
$0.28$7,125-27.12%

Insider Historical Profitability

<0.0001%
BROADWOOD PARTNERS, L.P.10 percent owner
6244405
37.0914%
$1.97130+2.24%
SMITH PATRICK W10 percent owner
1795071
10.6626%
$1.9770
Arno Andrewdirector
81554
0.4844%
$1.9770<0.0001%
James Andrea S.Chief Financial Officer
53670
0.3188%
$1.9720
Riggs JoshCEO and President
3505
0.0208%
$1.9710
BROADWOOD CAPITAL INC
23353697
138.7195%
$1.9710<0.0001%
Kamen Efrem
8520146
50.6091%
$1.9711<0.0001%
PURA VIDA INVESTMENTS, LLC10 percent owner
8090202
48.0553%
$1.9720<0.0001%
Lineage Cell Therapeutics, Inc.
6041154
35.8841%
$1.9703
KINGSLEY ALFRED Ddirector
469111
2.7865%
$1.9733<0.0001%
ANDREWS RONALD ASBURYPresident & CEO
333212
1.9793%
$1.9780+1.07%
Redmond Cavan M.
110863
0.6585%
$1.9720<0.0001%
Levine Mitchell SChief Financial Officer
87080
0.5172%
$1.9750+40.15%
Gutfreund John Peterdirector
75000
0.4455%
$1.9720<0.0001%
Last Andrew J.
70170
0.4168%
$1.9720<0.0001%
Carter Jennifer L.
30500
0.1812%
$1.9710<0.0001%
GRIFFITH MELINDA
30000
0.1782%
$1.9710<0.0001%
Ross Douglas T.Chief Scientific Officer
20317
0.1207%
$1.9710<0.0001%
Yu LiVP Cntrllr/Prncpl Acctng Offcr
16872
0.1002%
$1.9701
Paulsen GiselaChief Operating Officer
16500
0.098%
$1.9720<0.0001%
KALAJIAN TONY TSr.VP/Chief Accounting Officer
15000
0.0891%
$1.9720+163.52%
Parker Albert PChief Operating Officer
5000
0.0297%
$1.9710+163.52%
ANNETT WILLIAMPresident and CEO
3500
0.0208%
$1.9710<0.0001%
HESTERBERG LYNDAL K.Sr VP, Research & Development
874
0.0052%
$1.9710<0.0001%

OCX Institutional Investors: Active Positions

Increased Positions4+14.81%25,675+0.36%
Decreased Positions8-29.63%31,275-0.44%
New Positions0New0New
Sold Out Positions3Sold Out10,919Sold Out
Total Postitions23-14.81%7M-0.08%

OCX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Broadwood Capital Inc$10,203.0029%4.93M00%2024-09-30
Awm Investment Company, Inc.$2,271.006.45%1.1M00%2024-09-30
Pura Vida Investments, Llc$1,025.002.91%495,34500%2024-09-30
Vanguard Group Inc$508.001.44%245,388+899+0.37%2024-09-30
Geode Capital Management, Llc$215.000.61%103,980+11,289+12.18%2024-09-30
Blackrock, Inc.$165.000.47%79,833+7,006+9.62%2024-09-30
Morgan Stanley$150.000.43%72,289-6,407-8.14%2024-09-30
Fny Investment Advisers, Llc$102.000.29%49,377+6,481+15.11%2024-12-31
Defender Capital, Llc.$97.000.28%47,078-12,275-20.68%2024-12-31
State Street Corp$40.000.12%19,55400%2024-09-30
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.